Pending EO 12866 Regulatory Review

RIN: 0930-AA41	Received Date: 06/11/2026
Title: Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid (OFMG)
Agency/Subagency: HHS / SAMHSA	Stage: Notice
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No